{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:35:25Z","timestamp":1753893325480,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Liver transplantation (LT) is one of the most important treatments for children with liver cancer (CLCa) and has been increasingly used. However, there is a lack of large-scale and multicenter studies on the trend in the application and value of LT for the treatment of CLCa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analyzed the clinicopathological data of CLCa from 2000 to 2018 from the Surveillance, Epidemiology, and End Results (SEER) database. We explored the trend in the application of LT for the treatment of CLCa. <jats:italic>LASSO Cox<\/jats:italic> regression and the <jats:italic>Log-Rank<\/jats:italic> test were used to explore prognostic factors, and we built a nomogram using the screened factors. Propensity score matching was used to balance the baseline data of patients undergoing LT and other surgeries, and then the <jats:italic>Log-Rank<\/jats:italic> test was used to evaluate the therapeutic value of LT for CLCa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The 1-year, 3-year, 5-year, and 10-year overall survival (OS) rates of CLCa were 88.7%, 80.6%, 76.8%, and 73.0%, respectively. Then, we established a nomogram using many variables including age of diagnosis, regional lymph node metastasis, summary stage, and therapy. Internally validated and externally verified, our nomogram had good predictive power and clinical applicability. LT was increasingly being used to treat CLCa. There was no statistically significant difference in the OS of CLCa between the LT and other surgeries groups. After LT, the hepatoblastoma group had a better prognosis than the hepatocellular carcinoma group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We built a well-performing nomogram to predict the OS of CLCa. LT could improve the prognosis of CLCa as other surgeries and could be considered an effective treatment choice for CLCa.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2022.938254","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T05:51:48Z","timestamp":1661925108000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Competitive risk analysis of the therapeutic value of liver transplantation for liver cancer in children: A population-based study"],"prefix":"10.3389","volume":"9","author":[{"given":"Huiwu","family":"Xing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingman","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cld.2018.06.008","article-title":"Pediatric liver tumors","volume":"22","author":"Ng","year":"2018","journal-title":"Clin Liver Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/jhep.2003.50375","article-title":"Epidemiology of primary hepatic malignancies in U.S. children","volume":"38","author":"Darbari","year":"2003","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11020333","article-title":"Pediatric primary hepatic tumors: diagnostic considerations","volume":"11","author":"Lucas","year":"2021","journal-title":"Diagnostics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/s0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/lt.24847","article-title":"Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981\u20132015)","volume":"23","author":"Vinayak","year":"2017","journal-title":"Liver Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030720","article-title":"Liver transplantation for pediatric liver cancer","volume":"12","author":"Sindhi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00000658-196809000-00009","article-title":"Orthotopic homotransplantation of the human liver","volume":"168","author":"Starzl","year":"1968","journal-title":"Ann Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.surg.2012.11.006","article-title":"Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities","volume":"153","author":"Cruz","year":"2013","journal-title":"Surgery"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/lt.21654","article-title":"Liver tumors: pediatric population","volume":"14","author":"Finegold","year":"2008","journal-title":"Liver Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMA Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3322\/caac.21693","article-title":"Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B13","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.21037\/tlcr-21-562","article-title":"Development and validation of a nomogram for predicting survival in patients with surgically resected lung invasive mucinous adenocarcinoma","volume":"10","author":"Zhang","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"846276","DOI":"10.3389\/fmed.2022.846276","article-title":"Incidence trend and competing risk analysis of patients with intrahepatic cholangiocarcinoma: a population-based study","volume":"9","author":"Xing","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40880-019-0411-7","article-title":"Incidence trends and survival prediction of hepatoblastoma in children: a population-based study","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/cncr.33319","article-title":"Pediatric hepatic cancer incidence and survival: 30-year trends in Ontario, Canada; the United States; and Australia","volume":"127","author":"Di Giuseppe","year":"2021","journal-title":"Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/mcg.0000000000000833","article-title":"Racial disparities and sociodemographic differences in incidence and survival among pediatric patients in the United States with primary liver cancer: a Surveillance, Epidemiology, and End Results (SEER) population study","volume":"52","author":"Nautsch","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a\u00a0multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s1470-2045(21)00274-6","article-title":"Nomograms to predict outcomes after Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study","volume":"22","author":"Gafita","year":"2021","journal-title":"Lancet Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/s0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1634\/theoncologist.10-4-269","article-title":"Liver transplantation for malignancy","volume":"10","author":"Hertl","year":"2005","journal-title":"Oncologist"},{"key":"B23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/0016-5085(93)90852-4","article-title":"Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients","volume":"104","author":"Stone","year":"1993","journal-title":"Gastroenterology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/ajt.15697","article-title":"Liver transplantation for hepatocellular carcinoma: management after the transplant","volume":"20","author":"Verna","year":"2020","journal-title":"Am J Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16945","article-title":"Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: experience from the Society of Pediatric Liver Transplantation (SPLIT)","author":"Boster","year":"2022","journal-title":"Am J Transplant"},{"key":"B26","doi-asserted-by":"publisher","first-page":"100654","DOI":"10.1016\/j.aohep.2021.100654","article-title":"Management of hepatocellular carcinoma recurrence after liver transplantation","volume":"27","author":"Agarwal","year":"2022","journal-title":"Ann Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1399-3046.2007.00737.x","article-title":"Liver transplantation in pediatric patients: twenty years of experience at the University of Wisconsin","volume":"11","author":"D'Alessandro","year":"2007","journal-title":"Pediatr Transplant"},{"key":"B28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1067\/mpd.2000.106223","article-title":"Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence","volume":"136","author":"Reyes","year":"2000","journal-title":"J Pediatr"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.938254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T05:51:50Z","timestamp":1661925110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.938254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":28,"alternative-id":["10.3389\/fsurg.2022.938254"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2022.938254","relation":{},"ISSN":["2296-875X"],"issn-type":[{"type":"electronic","value":"2296-875X"}],"subject":[],"published":{"date-parts":[[2022,8,31]]},"article-number":"938254"}}